|
RNF115 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.818500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.246000E-01 |
| Normal-vs-Stage2 |
4.913000E-01 |
| Normal-vs-Stage3 |
3.39189999998268E-06 |
| Normal-vs-Stage4 |
1.90826999999505E-05 |
| Stage1-vs-Stage2 |
7.837400E-01 |
| Stage1-vs-Stage3 |
8.38600000000467E-05 |
| Stage1-vs-Stage4 |
3.788100E-04 |
| Stage2-vs-Stage3 |
1.127970E-02 |
| Stage2-vs-Stage4 |
9.997400E-03 |
| Stage3-vs-Stage4 |
9.428400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.120600E-03 |
| Normal-vs-AfricanAmerican |
2.485500E-02 |
| Normal-vs-Asian |
8.081800E-01 |
| Caucasian-vs-AfricanAmerican |
4.627000E-01 |
| Caucasian-vs-Asian |
3.468800E-01 |
| AfricanAmerican-vs-Asian |
2.619000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.966400E-04 |
| Normal-vs-Female |
1.189810E-01 |
| Male-vs-Female |
1.267610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.148200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.677700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.582600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.700600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.534360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.670400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.695800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.002800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.656000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.706400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.101830E-01 |
| Normal-vs-Grade 2 |
6.163400E-01 |
| Normal-vs-Grade 3 |
6.415100E-04 |
| Normal-vs-Grade 4 |
4.12270000360593E-08 |
| Grade 1-vs-Grade 2 |
7.963600E-02 |
| Grade 1-vs-Grade 3 |
8.099100E-03 |
| Grade 1-vs-Grade 4 |
4.46430000000664E-05 |
| Grade 2-vs-Grade 3 |
4.000200E-03 |
| Grade 2-vs-Grade 4 |
6.15120000047042E-07 |
| Grade 3-vs-Grade 4 |
9.035900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.406180E-01 |
| Normal-vs-ccB subtype |
1.94379999995942E-06 |
| ccA subtype-vs-ccB subtype |
3.28359994750116E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.856320E-02 |
| Normal-vs-N1 |
2.362100E-02 |
| N0-vs-N1 |
1.770210E-01 |
|
|
